ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is defined by the Philadelphia chromosome (Ph +), an acquired t(9;22)(q34;q11) translocation between BCR and ABL1 that produces the constitutively active BCR::ABL1 tyrosine kinase, driving malignant transformation in hematopoietic stem cells [1].